Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Satsuma Pharmaceuticals, Inc. | stsa-ex321_9.htm |
| EX-31.2 - EX-31.2 - Satsuma Pharmaceuticals, Inc. | stsa-ex312_8.htm |
| EX-31.1 - EX-31.1 - Satsuma Pharmaceuticals, Inc. | stsa-ex311_6.htm |
| EX-23.1 - EX-23.1 - Satsuma Pharmaceuticals, Inc. | stsa-ex231_7.htm |
| EX-4.6 - EX-4.6 - Satsuma Pharmaceuticals, Inc. | stsa-ex46_10.htm |
| 10-K - 10-K - 2020 - Satsuma Pharmaceuticals, Inc. | stsa-10k_20201231.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Satsuma Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company for the period covered by the Report. |
|
Date: March 25, 2021 |
|
By: |
/s/ Tom O’Neil |
|
|
|
|
Tom O’Neil |
|
|
|
|
Chief Financial Officer (Principal Financial and Accounting Officer) |